Coming to America: Genomic surveillance and how B.1.1.7 arrived in the US

In this issue of Cell, Washington et al. and Alpert et al. demonstrate the value of genomic surveillance when studying the introduction of the B.1.1.7 variant to the US and illustrate the challenge that results from the lack of good sampling strategies. In this issue of Cell, Washington et al. and A...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cell 2021-05, Vol.184 (10), p.2532-2534
Hauptverfasser:	Qiu, Xueting, Hanage, William P., Taylor, Bradford P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Communicable Diseases, Emerging - epidemiology Communicable Diseases, Emerging - virology COVID-19 - epidemiology COVID-19 - virology Epidemiological Monitoring Humans Metagenomics - methods Preview SARS-CoV-2 - genetics SARS-CoV-2 - isolation & purification United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In this issue of Cell, Washington et al. and Alpert et al. demonstrate the value of genomic surveillance when studying the introduction of the B.1.1.7 variant to the US and illustrate the challenge that results from the lack of good sampling strategies. In this issue of Cell, Washington et al. and Alpert et al. demonstrate the value of genomic surveillance when studying the introduction of the B.1.1.7 variant to the US and illustrate the challenge that results from the lack of good sampling strategies.
ISSN:	0092-8674 1097-4172 1097-4172
DOI:	10.1016/j.cell.2021.04.031